subscribeSubscribe
Amgen`s Biologic Aimovig (Erenumab) Receives Approval in the U.S.

Amgen`s Biologic Aimovig (Erenumab) Receives Approval in the U.S.
FDA
03 Oct 2022
Share Share
Amgen`s Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.

Amgen`s Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.
FDA
15 Aug 2022
Share Share
Novartis, Amgen settle their yearslong Aimovig dispute

Novartis, Amgen settle their yearslong Aimovig dispute
E. Sagonowsky FIERCEPHARMA
02 Feb 2022
Share Share
Aimovig displays superiority over topiramate in migraine study

Aimovig displays superiority over topiramate in migraine study
Anna Begley EUROPEANPHARMACEUTICALREVIEW
09 Nov 2021
Share Share
AbbVie follows Biohaven into oral CGRP for migraine prevention

AbbVie follows Biohaven into oral CGRP for migraine prevention
Angus Liu FIERCEPHARMA
29 Sep 2021
Share Share
AbbVie`s oral migraine treatment atogepant nears FDA decision

AbbVie`s oral migraine treatment atogepant nears FDA decision
Annalee Armstrong FIERCEBIOTECH
20 Aug 2021
Share Share
Amgen’s Aimovig gets Japanese marketing approval

Amgen’s Aimovig gets Japanese marketing approval
PHARMABIZ
23 Jun 2021
Share Share
Amgen Announces Approval Of Aimovig® (Erenumab) In Japan

Amgen Announces Approval Of Aimovig® (Erenumab) In Japan
PRNEWSWIRE
23 Jun 2021
Share Share
Novartis hands U.S. operations for migraine drug to Amgen

Novartis hands U.S. operations for migraine drug to Amgen
N. H. Dunn FIERCEPHARMA
16 Jun 2021
Share Share
Novartis’ migraine medicine trial meets endpoints

Novartis’ migraine medicine trial meets endpoints
CLINICALTRIALSARENA
03 Nov 2020
Share Share